Assessment  of Patient Satisfaction upon Establishment of  Pharmaceutical Care in Oncology by Linu, Babu
 
 
ASSESSMENT OF PATIENT SATISFACTION UPON 
ESTABLISHMENT OF PHARMACEUTICAL CARE IN ONCOLOGY 
 
 
Dissertation Submitted to 
The Tamil Nadu Dr. M.G.R.  Medical University, Chennai 
In partial fulfillment for the Award of the Degree of 
 
MASTER OF PHARMACY 
(Pharmacy Practice) 
APRIL 2014 
 
Submitted by 
Reg.No.261240610 
 
Under the guidance of 
Mr.V.SIVAKUMAR, M.PHARM. 
 
  
DEPARTMENT OF PHARMACY PRACTICE 
KMCH COLLEGE OF PHARMACY 
KOVAI ESTATE, KALAPATTI ROAD, 
COIMBATORE – 641 048 
 
PROF. Dr. A. RAJASEKARAN, M.PHARM., PH.D., 
PRINCIPAL, 
KMCH COLLEGE OF PHARMACY,   
KOVAI ESTATE, KALAPPATTI ROAD, 
COIMBATORE – 641 048.  
 
                                                       
CERTIFICATE 
 
     This is to certify that the dissertation work entitled “Assessment of Patient 
Satisfaction  upon Establishment  of  Pharmaceutical  Care in Oncology”  submitted by 
REG.NO.261240610 is a bonafide work carried out by the candidate under the guidance of   
MR.V.SIVAKUMAR, M.Pharm., and submitted to The Tamilnadu Dr.  M.G.R Medical 
University, Chennai, in partial fulfillment for the Degree of MASTER OF PHARMACY IN 
PHARMACY  PRACTICE during the academic year 2013-2014.     
 
 
PROF. Dr. A. RAJASEKARAN, M.Pharm., Ph.D., 
  PRINCIPAL 
 
Place: Coimbatore 
Date:
Mr. V. SIVAKUMAR, M.Pharm. 
ASSISTANT PROFESSOR, DEPARTMENT OF PHARMACY PRACTICE, 
KMCH COLLEGE OF PHARMACY 
KOVAI ESTATE, KALAPATTI ROAD, 
COIMBATORE – 641 048. (T.N) 
 
 
CERTIFICATE 
 
            This is to certify that the dissertation work entitled “Assessment of Patient Satisfaction  
upon Establishment  of  Pharmaceutical  Care  in  Oncology” submitted by 
REG.NO.261240610 is a bonafide  work carried  out by the candidate  under my guidance  to  
The Tamil Nadu Dr. M.G.R. Medical University, Chennai, in partial fulfillment for the Degree of   
MASTER OF PHARMACY in PHARMACY PRACTICE at the Department of Pharmacy Practice,  
KMCH College  of Pharmacy, Coimbatore, Tamil Nadu during the academic year 2013– 2014. 
 
                                                                                  Mr.V.SIVAKUMAR, M.Pharm. 
 
Place: Coimbatore 
Date: 
                                                                 
 
 
 
DECLARATION 
 
           I do hereby declare that the dissertation work entitled “Assessment of Patient 
Satisfaction  upon Establishment  of  Pharmaceutical  Care  in  Oncology” submitted to   the 
Tamil   Nadu Dr. M.G.R. Medical University, Chennai in the partial fulfillment for the Degree of 
MASTER OF PHARMACY IN PHARMACY PRACTICE, was done under  the guidance of                          
MR. V.SIVAKUMAR.,M.PHARM at the Department of Pharmacy Practice, KMCH College of 
Pharmacy, Coimbatore, Tamil Nadu during the academic year 2013-2014. 
 
 
 
  
MRS. LINU BABU 
Reg. No:261240610 
 
 
  
 EVALUATION CERTIFICATE 
 
This is to certify that the dissertation work entitled “Assessment of Patient Satisfaction  
upon Establishment of Pharmaceutical Care  in  Oncology” submitted by MRS. LINU BABU 
University Reg No: 261240610 to The Tamil Nadu Dr. M.G.R. Medical University, Chennai, in 
partial fulfillment for the Degree of MASTER OF PHARMACY is  a  bonafide  work  carried  out  
by   the candidate  at the  Department of Pharmacy Practice, KMCH College of Pharmacy, 
Coimbatore, Tamil Nadu and was evaluated by us during  the  academic year 2013-2014. 
 
 
Examination Center:   KMCH College of Pharmacy, Coimbatore   
Date: 
 
 
 
Internal Examiner                                                                               External Examiner 
 
 
 
Convener of Examination 
                       
         
  
 
 
 
Acknowledgement 
 
Department of Pharmacy Practice 
ACKNOWLEDGEMENT 
“The attitude of gratitude can raise your altitude; being thankful is a magical way to reach 
the top”                                                                                          -Unknown Author 
                          I  take  this occasion  to  owe  my  indebted  gratitude  towards  all those  who 
have  continued  to support  me  accomplish  this  project.  
                          Dear  God,  from  the  bottom  of  my  heart,  I  want  to thank  you  for  being  
with  me all  the  way,  for  never  leaving me,  for  loving  me  and   I  shall  never  fail  in  any  
of  my endeavors  with  your  blessings.                                                         
                         This  journey would  not  have  been  possible without  the  support  of  
my   family.  I am most deeply grateful to my loving parents Mr. BABU. K.JOHN and 
Mrs. MINI BABU who supported me throughout my journey of studies. I always  knew  
that  they  believed  in  me  and  wanted  the  best  for  me. I  express  my  warm  
gratitude   to  my beloved  husband  Mr. NITHIN JOSEPH  for encouraging  me   in  all  
of  my  pursuits  and  inspiring  me  to  follow  my  dreams. 
                         “The true value of a teacher is determined not by what he knows, nor by 
his ability to impart what he knows, but by his ability to stimulate in others a desire to 
know.”                                                                                        -Prof. Robert Lee Madison. 
                       I cannot emphasize enough the importance of my guide, in its full sense of 
the word, he has guided me at each stages of the study and inspired me to explore the 
fields of knowledge. It is my silent privilege to tender my sense   of deep  gratitude to  
Mr. V.SIVAKUMAR, M.Pharm. Assistant Professor, Department of Pharmacy Practice, 
KMCH college of Pharmacy, Coimbatore.     
                        At this juncture, I am swamped by the prodigious help and advices of my 
clinical guide Dr. SUDHAKAR N, MBBS MD DM., (ONCOLOGY). In spite of his tight 
scheduled medical practice, he found time for discussions, suggestions and anchored a 
chief role in completion of this mission.                
Acknowledgement 
 
Department of Pharmacy Practice 
                          I express my heartfelt gratitude and thanks to our chairman Dr. NALLA 
G.PALANISWAMI, M.D., AB (USA)., and our trustee madam Dr. THAVAMANI D. 
PALANISWAMI, M.D., AB (USA) of Kovai Medical Centre research and Educations 
Trust (KMCRET), Coimbatore for providing me with all the facilities to carry out this 
work in such an esteemed corporate hospital. 
                         I put  across  my honest thanks and gratitude to our  Principal,            
Prof. Dr. A.RAJASEKARAN M.Pharm., Ph.D., KMCH College of Pharmacy, 
Coimbatore, for providing  us  with  a cooperative  environment to  work  excellently.   
                        It is my pleasure to extend my sincere thanks to all my beloved staff 
members Dr. SUCHANDRA SEN, M.Pharm., Ph.D., Mr. A. VIJAYAKUMAR 
M.Pharm., Mrs. K. GEETHA M.Pharm., Mr. K.CHANDRASEKARAN, M.Pharm., and 
Mr. S. PALANISWAMI M.Pharm.,Ph.D. for their support at times of need and valuable 
suggestions. 
                        I take this opportunity to thank the crew which includes nursing staffs, 
secretaries Ms.SANGEETHA and Ms.JYOTHI at KMCH Comprehensive Cancer 
Centre, pharmacists and lab technicians. It was wonderful of them to keep contributing 
to this type of work and it really shows how the healthcare community really is.        
                        My gratitude to people who have picked me up and held my hand along 
the way is unquestionable. To mention few of their names, Mrs. DIVEA JENNY,   
Miss. SHARON ELIZABETH, Miss. DEETHU DAS, Miss. ANAGHA RAGHAVAN, 
Miss.  TEENA TREESA,  Miss  JIJI ALFRED, Miss SEIRA  MARIYAM THOMAS  
and Mr.ARUN N.A; Each of you has given me your time, energy and expertise and I 
am richer for it.    
                          The most important and thanks deserving group in my study is the 
patients of Oncology ward whose corporation and acceptance was my strength and 
leading force to complete the study at the right pace and with the right spirit. I extend my 
gratitude to each one of them and their family members from the bottom of my heart.   
Acknowledgement 
 
Department of Pharmacy Practice 
                            Last but not the least, I would also like to thank my seniors, juniors , 
my well-wishers and all those who directly or indirectly helped and encouraged me in 
the completion of this thesis as without their prayer this entire endeavour would not 
have been accomplished.        
 
 
   Abbreviations 
 
  
 
 
ABBREVIATIONS 
ADE   - Adverse Drug Events 
ADR  -            Adverse Drug Reaction 
CNS  - Central Nervous System 
CTRC  - Cancer Therapy & Research Center  
DDI  - Drug-Drug Interaction 
DRP     -           Drug Related Problem 
GI  - Gastrointenstional 
MCMM - Multiprofessional Cancer Medication Management  
NSAIDs - Non-Steroidal Anti Inflammatory drugs 
OTC  - Over the Counter  
PIL  - Patient Information Leaflet 
PPE  - Palmar Plantar Erythrodyspepsia 
PS-CaTE        -           Patient Satisfaction with Cancer Treatment Education 
QoL  - Quality of Life 
SCP   - Seamless Care Programme 
Sig  - Significance 
TOPCaBS - The Oddedina Prostate cancer screening behaviour scale 
                   Index 
  
 
 
INDEX 
 
SL. NO 
 
CONTENTS 
 
 
PAGE NO.  
 
1 
 
INTRODUCTION 
 
01-03 
 
2 
 
REVIEW OF LITERATURE 
04-14 
 
3 
 
METHODOLOGY 
15-22 
 
4 
 
 
RESULTS 
 
23-27 
 
5 
 
TABLES AND GRAPHS 
28-43 
 
6 
 
DISCUSSION 
44-52 
 
7 
 
CONCLUSION 
53 
 
8 
 
RECOMMENDATIONS 
54 
 
9 
 
BIBLIOGRAPHY 
 
 
10 
 
ANNEXURES 
 
  
Annexure 1 : Modified PS-CATE questionnaire 
Annexure 2 : Data Collection Form 
 
Annexure 3 : Patient Information Leaflet 
 
 
 
    Introduction 
 
  Page 1 
 
INTRODUCTION 
                   A cancer diagnosis places considerable stress on patients and their families. They 
find  themselves discomfort with the strange health system; making serious decisions with long 
term consequences; living with uncertainness about the nature, cause and indefinite progress of 
the disease; living with a disrupted family, work, social life and facing the possibility of 
becoming increasingly dependent on others
1
. 
                  Pharmaceutical care is initiated in the oncology department of our hospital to create a 
better experience for cancer patients by delivering patient centered care.  In 1990, Helper and 
Strand introduced the concept of pharmaceutical care. They understand pharmaceutical care as a 
responsible provision of drug therapy for the purpose of achieving definite outcomes that 
improves the patients’quality of life2. Further pharmaceutical care is considered as a patient 
centred, outcome oriented pharmacy practice that requires the qualified pharmacist to work in 
concert with the patient and other health care provider.
3
 ‘Patient perception of care’ encompasses 
both patient satisfaction and their experience of care. Patient satisfaction is a subjective, 
evaluative assessment that is derived from expectations, needs, past experiences, opinions and 
attitudes
4
. 
                 In recent years, awareness has risen of how patients perceive the quality of their health 
care
5,6
. Consequently, patient satisfaction assessment has become an important tool to gain 
attention and value amongst the health care system. It has become increasingly important for 
health care professionals to systematically measure patients’ perceptions of and satisfaction with 
their care. Evaluation of patient satisfaction in oncology involves a diverse array of 
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methodologies that includes in-depth interviews, focus discussion groups, consultation of 
voluntary groups and analyses of complaints and surveys. However patient satisfaction survey 
still continues to be the most widely used mode of objectively and systematically determining 
cancer patient’s perception of the health care received7. 
          Particularly in cancer patients, stress is a factor that affects them emotionally and 
contributes to least satisfaction to a greater extend.. Patient’s stress can be amplified by long 
waiting room times, lack of information and poor communication between clinic staff and 
patients
8
. Cancer patients showed a desire for maximum amount of information regarding their 
treatment, preferred for open communication about their illness and displayed high levels of 
hope to develop coping strategies and to initiate self- care behavior
9
. The Ottawa charter for 
health promotion initiated this noel way of approach. It emphasizes the relevance of treatment 
education for patients to increase control over their health and to be able to take responsibility for 
their well-being
10
.  
                    Educating the patient or representatives regarding the treatment, medication 
information on directions of use, prevention and management of adverse effects, storage and 
lifestyle modifications, verbally or in a written form altogether comes under patient counselling. 
Pharmacists may use patient information leaflets which may result in improved understanding 
and acceptance of treatment reccomendations
11.
Many a times, pharmacist cannot identify and 
manage all of the drug related problems that patient experience. Rather, the goal should be to 
maximize patient benefit with available resources. Pharmacist need to identify those problems 
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for which management or prevention would result in the greatest benefit for as many patients as 
possible
12.
. 
.              At the other side, clinical role of pharmacist in oncology as well as in other departments 
remained neglected for years within India. The pharmacists themselves have shown reluctance 
towards assuming such clinical role and responsibilities. However, this scenario has started 
undergoing promising changes in the recent past
13
. As part of establishment of pharmaceutical 
care in the oncology department of our hospital, we utilize this study to contribute patient 
oriented services and also to find out the effectiveness of the service upon their satisfaction, thus 
show the importance of pharmaceutical service in clinical setup.                      
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2. REVIEW OF LITERATURE 
A literature review of 23 relevant articles on the various aspects of pharmaceutical 
care and patient satisfaction in oncology published between March 1999 and September 2013 
is discussed here and it led us to organize the study in a progressive manner.  
A survey was done in Germany by Liekweg et al to measure patient satisfaction with 
information in cancer treatment and to support the development of pharmaceutical care 
strategies for cancer patients by detecting and compensating information deficiencies. The 
Canadian PS-CaTE was translated into German. They have distributed the questionnaires  to 
two groups, the pre-test group and main test group. The pre-test group was intended to check 
the reliability of instrument and main test group to find out the satisfactory levels on a 5 point 
Likert scale. Out of 47 completed questionnaires, the pre-test established a good reliability of 
the instrument. From their main survey, 232 questionnaires showed a median score of 3.5, 
where 5 represented the highest degree of satisfaction. Their findings could motivate 
pharmacists to actively provide information for cancer patients. The assessment of patient 
satisfaction can contribute to the outcome evaluation of pharmaceutical care
14
. 
Lorenzo et al., conducted a study in Italy in order to find out how Italian cancer 
patients rate the information they are given and whether the use of booklets and videotapes 
can improve their quality of life. Cancer patients between the age of 18-80 were included in 
the study at their first cycle of chemotherapy and randomized to fill in questionnaire on 
perceived quality of information, level of psychological distress, perceived severity and 
curability of disease and Quality of Life (QoL) .In a total of 328 patients from 21 cancer 
centres, 86-93% considered the booklets are either “very useful” or “useful”. The videotape 
was regarded “quite” or “much” complete than the booklet (87%). 81% of patients reported 
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the information given to them had improved their knowledge   about disease / chemotherapy 
“a lot” and 87% reported “enough”. The study has concluded that information patients 
received from the oncologist is highest rated as long as they were devoted enough time. 
Booklets and videotapes can partially overcome the lack of oral information given by doctors. 
They also suggest that a better informed patient does help the oncologist save time
15
. 
An observational study was conducted by Mckee et al., on patient satisfaction with 
pharmacy services at CTRC, Texas to assess the role of the patient-pharmacist relationship 
and enhance patient satisfaction with care. They have developed a survey tool of 20 item, 2 
page and administered to oncology patients in the time period of December 2009 to February 
2010.  They have also measured time spent with pharmacists, knowledge of medication 
therapy and willingness to pay for clinical pharmacy services. From this cross sectional 
study, 86%  stated that it is important for patients to discuss their treatment with a pharmacist 
and 76% requested pharmacy follow-up at future visits. Their study also says that the patients 
were willing to pay for pharmacy counselling services
16
. 
Ruder et al conducted a retrospective descriptive analysis of clinical interventions by 
the clinical oncology pharmacist from September 2004-October 2006 to describe clinical 
interventions and assess the impact of consultation by the clinical oncology pharmacist on 
patient care. The interventions were categorised as drug related and consultative.Drug related 
interventions included medical reconciliation, dosing, adverse effect management and 
prevention. Consultations incorporated drug information questions, patient visits and patient 
education sessions. They have documented 583 clinical interventions among 199 patients. 
Average time spent was 10 minutes. Their results revealed that drug related and consultative 
interventions accounted for 35% and 65% respectively. They have also received a feedback 
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results from patients and colleagues which evaluated the pharmacist services with positive 
ratings of 95% and 98% respectively
17
. 
Albada et al., conducted a study to assess the effects of a pre-visit website with 
tailored information and question prompt sheet on breast cancer patients. A total of 197 
counselees were randomized to receive usual care  and intervention group who received usual 
care along with website information about genetic counselling and all patients completed a 
pre and post visit questionnaire. From their study, counselees in the intervention group 
(n=103) had higher levels of recall of information from consultation (p=0.02) and better 
fulfilment of information needs (p=0.03). They have concluded that pre-counselling can lead 
to more effective for first visit breast cancer genetic counselling
18
.  
Edwards et al., evaluated pharmacist directed Seamless Care Program conducted at 
the Dr.H.Bliss Murphy Cancer Centre in Canada. Their study was designed in such a way 
that the patient received SCP visits before and after the chemotherapy treatment was 
intended. SCP performed a thorough medication safety check to verify the order against 
regimen protocols, including a drug interaction check, recalculation of the dose and 
verification of patient laboratory values. The program has also counselled the patients on 
their treatment, identified and resolved any DRPs. They have divided the total study 
population of 200 to 100 in control group and 100 in intervention group. The study identified 
an average of 3.7 DRPs per intervention patient. They have also found out that the patients 
receiving adjuvant treatments  were identified to have more DRPs compared to those 
receiving palliative treatment. They have also assessed their intervention satisfaction from the 
physicians, oncology nurses and pharmacists and got a positive result with the information 
collected and distributed by SCP. This study was limited to intervention group. A comparison 
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of intervention and control groups could have extracted more differences in quality of life 
measures and healthcare professional needs
19
.  
A prospective study was carried out by Wong WS et al., to evaluate the impact of 
clinical pharmacist in ambulatory hematology-oncology clinics. Patients who were newly 
diagnosed, had multiple medical problems, or took three or more medications were selected 
and reviewed one day prior to their clinical visits. The study has recorded the clinical 
significance of the pharmacist interventions and patient outcomes. 211 pharmacy 
interventions were documented within a 36 day period. The most frequent pharmacy activity 
was patient counselling followed by therapeutic recommendations. The results showed 13.7% 
interventions were chemotherapy related and 86.3% were not.94.8% interventions were 
accepted by physicians and other healthcare professionals. Thus they concluded that clinical 
pharmacist in outpatient hematology-oncology can result in decreased health care cost and an 
improvement in quality of patient care 
20
. 
Iconomou et al, conducted a study to identify the specific informational needs of 
primary caregivers of cancer patients receiving chemotherapy in a Greek outpatient setting 
and to assess their preference for cancer-specific booklets, their levels of satisfaction with 
communication and their psychological status. They have also examined whether their need 
for information was associated with their preference for written information, level of 
satisfaction, and levels of psychological distress and to find possible associations between 
satisfaction and psychological distress. 78 caregivers participated in the study and data were 
collected by structured individual interviews. Their results show that the main findings to 
emerge were that a significant proportion of the caregivers had elevated needs for 
information, which were positively associated with a preference for cancer-specific printed 
material. Participants experienced heightened levels of anxiety and depression, which were 
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independent of the need for information, preference for printed material or satisfaction with 
communication. In addition, the rates of anxiety and depression observed highlight the need 
for a more thorough evaluation and management of caregivers' psychological morbidity in 
their oncology setting
21
. 
 
Another study by Sherlaw-Johnson et al., investigated cancer patient satisfaction 
with care and the extent to which it varies between and within hospitals. Dissatisfaction was 
greater in younger, female patients. Breast cancer patients expressed least, and prostate 
cancer patients expressed greatest dissatisfaction. Hospital satisfaction varied by cancer type 
(for breast, colorectal and prostate cancer patients), and with more effect on in-hospital than 
out-of-hospital care. Breast, colorectal and prostate cancers showed significant pair-wise 
correlations for standardized satisfaction scores, particularly for in-hospital care
22
. 
Bremberg ER et al., conducted a study to establish the importance of a pharmacist in 
the health care team to improve drug use in an oncology ward in a Swedish hospital. They 
identified DRPs and used a questionnaire to evaluate pharmacist contribution in oncology 
ward.114 DRPs were identified in 58 patients. Pharmacist gave solutions for each drug 
related problem.78 suggestions (59.6%) out of 114 were implemented by physician. Two 
were partly followed, whereas 32 suggestions were not clear if any changes were made.12 
suggestions were not followed. Completed questionnaires were collected from 58% of 
physicians and 55% from which it was concluded that a pharmacist can improve drug use and 
optimize the therapy in the oncology ward as a member of healthcare team
23
. 
A prospective, descriptive, cross-sectional study of interventions made by pharmacists 
in dispensing of chemotherapy doses was conducted by Knez L et al., at a tertiary cancer 
centre in London. The pharmacists were shadowed by two research pharmacists during the 
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clinical screening of chemotherapy prescriptions and release of prepared drugs. An expert 
panel of pharmacy staff rated the clinical significance of the recorded interventions. Twenty 
one pharmacists‟ interventions recorded from 130 prescriptions. ”Drug and therapy” (38%), 
clerical (22%) and “dose, frequency and duration”(19%) related problems, most often 
required an intervention, identifying areas in chemotherapy prescribing that need 
improvement. The proposed recommendations were implemented in 86% of the cases. Many 
recorded interventions (48%) were ranked to have had a “very significant” influence on 
patient care. Thus the study concludes clinical interventions made by pharmacists had a 
significant impact on patient care. It also states that the integration of pharmacists‟ technical 
and clinical roles into dispensing of chemotherapy doses is required for providing high-
quality cancer services
24
.  
Odedina FT et al., conducted a cross sectional study to explore the role of 
pharmacists in Florida as health educators and risk communicators in the prevention of 
prostate cancer. They have also assessed the knowledge of pharmacist about prostate cancer 
by using TOPCaBS. Their results showed 55% of participants scored 80% on the knowledge 
scale, whereas 15% scored less than 60%. 95% of pharmacists in their study would like to 
have additional training on prostate cancer which may be beneficial to patients. Thus, this 
study concluded that pharmacists were willing to take responsibility of health education and 
risk communication in prevention and detection of prostate cancer
25
. 
In a survey conducted by Taylor et al., to report the impact on patient satisfaction by 
routine counselling on Natural Health Products (NHP) which are commonly used by cancer 
patients, the patients visited the cancer centre for the first time were recruited before (control) 
and after (intervention) the introduction of routine structured counselling by a pharmacist. 
Out of 265 completed questionnaires, the scores for overall and all subscales were 
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significantly increased in the intervention group. They have concluded that patient 
satisfaction increased with the routine structured patient counselling
26
.               
Jansen et al., evaluated (1) whether early-stage breast cancer patients perceived that 
they had treatment choice with regard to adjuvant chemotherapy, (2) what reasons patients 
provide for their perception of having had no choice of treatment, and (3) whether the 
perception of treatment choice is related to the satisfaction with the assigned treatment, 
experienced chemotherapy burden and QoL. A total of 448 patients, treated between 1998 
and 2003, filled in the questionnaire. Of the 405 patients answered the question on treatment 
choice, 316 patients (78%) had perceived no choice. The most frequently indicated reason for 
lack of choice was: „I follow the doctor‟s advice.‟ The authors found no difference in the 
levels of satisfaction with assigned treatments. However, they found an interaction effect, 
which indicated that the impact of perception of treatment choice on QoL was dependent 
upon whether the patient had been treated with chemotherapy or not. The study concluded 
that in cases when the decision to be treated or not has the potential consequences for the 
chance of survival, patients‟ QoL may not be improved by the perception of having had a 
choice of treatment
27
. 
Miranda et al., investigated how many hospital admissions in oncology are related to 
a DDI or an ADR. The study was designed to include all cancer patients admitted to 
oncology ward during an eight-month period. They have retrospectively evaluated the charts 
of each patients for reasons of hospitalization, using a 4-point scale (definitely, probably, 
possibly, or unlikely associated). A total of 458 admissions were eligible and among 
unplanned admissions (n=298), 39 were considered to be associated with an ADE,33 with an 
ADR, and six with a DDI. The most common DDI involved warfarin, captopril, and anti-
inflammatory agents, and the most frequent ADR was neutropenic fever post-chemotherapy. 
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Thus the conclusion of the study shows one in 10 unplanned hospitalizations of cancer patient 
is associated with an ADE
28
. 
Yet another study was conducted by Dohler et al., in Germany to define the task 
allocation in multiprofessional cancer medication management with a special focus on the 
role of pharmacist as well as patient education and counselling. As part of the study they have 
held local focus group meetings to identify MCMM tasks. They have included professionals 
from German Cancer society to evaluate the acceptance of MCMM model. As a result the 
MCMM model comprised of 38 tasks in which 11 on patient education and counselling. The 
study rated it reasonable (79% ) and feasible (68%) respectively. The barriers and benefits of 
multi-professional team-works stated were patient,-team,-therapy,-structure and resources 
related. The study came to a conclusion by integrating pharmacist with responsibilities in 
patient education and counselling and prevention of drug related problems
29
. 
Annunziata MA et al., conducted a prospective study in 175 patients to evaluate the 
impact of information level on quality of life in cancer patients previously studied for their 
information level. The information level was determined by means of a questionnaire that 
explored the degree of information on diagnosis and status of disease, the patient's 
interpretation of disease status, and  satisfaction with the information received. Their study 
also evaluated Quality of life, some months after evaluation of the information level, by 
means of the Functional Living Index for Cancer (FLIC) and the State-Trait Anxiety 
Inventory (STAI 1-2). The result revealed the information was adequate in 53.7% patients. 
An adequate level of information was present more frequently among patients aged < or = 65 
years and in those patients followed at a cancer institute. There was no difference in the 
quality of life of adequately versus inadequately informed patients. Satisfaction with the 
information received influenced quality of life in both age groups. The objective clinical 
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variables (active disease present and ongoing treatment) negatively affected quality of life in 
patients <65 years, whereas the subjective perception of the presence of disease was 
associated with a worse quality of life in older patients. The study concluded that, although 
the level of information did not affect the quality of life, satisfaction with the information was 
associated with a better quality of life
30
.  
Another prospective study conducted by Mc Lennan ND et al., in oncology referral 
centre concluded that a higher rate of beneficial outcomes was achieved by pharmacist 
interventions. They have studied 1493 admitted patients to determine the clinical outcomes 
associated with pharmacist interventions in a period of two months.674 interventions were 
documented for 295 patients. The results showed that more than one intervention was 
required for 47% patients and the clinical outcomes for 10% of interventions were assessed 
and the remaining 90% resulted in documented clinical benefit
31
.  
In another study by Liekweg et.al stated that pharmaceutical care concepts have a 
good potential of supporting the idea of drug management programs. They have summarized 
pharmacy services in oncology department as central cytotoxic services, drug information 
services, therapeutic drug monitoring, nutritional support, parenteral medications, unit dose 
system, compilation of medication history and pharmaceutical care. Patient adherence can be 
improved by patient education and counselling before and during treatment, regarding the 
drug therapy, adverse effects and complementary treatment. They have reported an increased 
satisfaction with cancer treatment education. Thus concluded that pharmaceutical care 
concepts support idea of supportive care and may be integrated in disease management 
process
32
.  
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Davidson et al., examined 435 cancer patients throughout Northern Ireland during a 
three-month period. While overall satisfaction scores were relatively high, there was 
considerable variation. The interaction between perceived satisfaction scores were relatively 
high , there was considerable variation. The interaction between perceived satisfaction and 
quality of care, communication, tumor site, and age was significant. The younger patients 
(<45 years) were less satisfied with communication of diagnosis than the older patients. They 
were also less satisfied with the privacy in the outpatient clinic when the tests were carried 
out and the time it took for the diagnosis to be reached. From the results, those patients with 
high incidence of tumors, i.e., breast, lung and colorectal reported significantly higher 
satisfaction than patients suffering from „other cancers‟, i.e., prostate, gynaecological and 
gastric cancers
33
. 
N. Sreelalitha et al., discussed about the pharmaceutical care services provided by 
the pharmacists in Indian scenario. They consider pharmacy as a major component in the 
health care system is under reprofessionalism and the care concept requires pharmacists to 
change their practice from product oriented to patient oriented. The study also shows that the 
provision of pharmaceutical care requires monitoring the regimen‟s effects, revising the 
regimen as the patient‟s condition changes, documenting the results, and assuming 
responsibility for the pharmacotherapeutic effects
13
. 
Broadfield L collected information on a set of toxicity outcome indicators from a 
multidisciplinary group and implemented at the Hamilton Regional Cancer centre. A revised 
system for chemotherapy ordering and documentation was implemented. Orders were written 
for complete protocols, rather than individual drugs. At each patient visit along with orders 
for chemotherapy drugs, supportive care medications, blood results. Each patient was also 
rated for four common toxicities of chemotherapy like vomiting, diarrhoea, nausea and 
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stomatitis. Pharmacists in the dispensary, review these toxicity ratings, as each dose of 
chemotherapy is validated before dispensing, thus making interventions if needed
34
.   
Feyer et al., conducted a study to examine the frequency of side effects and fatigue in 
ambulatory cancer patients and analysed how these symptoms are reflected in patient 
satisfaction.  41 private practices and 8 day hospitals in Germany took part in the study. The 
respondents were 4,538 patients with cancer (response rate: 82%). The diagnoses were: 25% 
breast cancer, 21% colorectal cancer, 11% lymphomas and 12% haematological 
malignancies. The most frequent single side effects were fatigue (60%), hair loss (54%), 
nausea (51%), sleep disturbance (42%), weight loss (36%), diarrhoea (32%) and mouth 
ulcerations (31%). The results revealed no significant association between total number of 
side effects and patient satisfaction. It was concluded that side effects and especially fatigue 
are frequent problems in cancer patients and are related to the patients‟ assessment of cancer 
care
35
.  
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3. METHODOLOGY 
A prospective interventional study on assessment of patient satisfaction upon establishment of 
pharmaceutical care was conducted in Kovai Medical Centre and Hospital, Coimbatore.. 
Objective:  
Primary Objective – Assessment of patient satisfaction upon the establishment of                   
pharmaceutical care. 
Secondary Objective - Establishment of Pharmaceutical care and improvement in patients’ 
quality of life 
Study Site: 
We received Ethics Clearances from “KMCH ETHICS COMMITTEE” in order to conduct the 
study in Kovai Medical Center and Hospital, Coimbatore. 
Study Period:  
The study was carried over a period from the month of May 2013 to February 2014. 
 Study Population: 
Inclusion Criteria: 
 Patients diagnosed with cancer and admitted for chemotherapy. 
 Patient selection determined by physician. 
 Patients from whom oral consent is received. 
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           Exclusion Criteria: 
 No special exclusion criteria 
Study Materials 
1) Modified-Patient Satisfaction with Cancer Treatment Education Questionnaire. (PS-
CaTE) (Adopted from Canadian PS-CaTE questionnaire)
14
 (Annexure I) 
           The PS-CaTE questionnaire measures patients’ satisfaction with the information they 
received about their chemotherapy. It is used to assess the service given by the pharmacist upon 
patient counselling and its effect on perceived satisfaction. Additionally one question was added 
to measure the satisfaction with information provided on handling of drugs. Use of herbs and 
vitamins mentioned in the original questionnaire was modified by including use of drugs.  
The questionnaire consists of three parts.  
Part I - Sociodemographic characteristics of the patient. 
Part II- Sources of information regarding chemotherapy utilized by the patients  
Part III- Contains 15 questions that evaluates the patients’ perception on the information given 
during their cancer treatment on a five point Likert scale. 
0 = Not specified, 1 = strongly disagree, 2 = disagree, 3 = uncertain,4= agree, 5 = strongly agree. 
 
2)  Data Collection Form (Annexure II) 
 
This is the form used to collect individual details like name, age, sex, past medical                                                  
history and medication history, diagnosis, and chemotherapy. 
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3) Patient Information Leaflet (PIL) (Annexure III) 
Patient information leaflet consists of the information regarding the common side effects, 
the detection and the management of side effects along with general instructions to be 
followed by a patient receiving chemotherapy. 
Study Procedure 
The whole study consists of three phases. 
Phase I- includes the preparation of supportive materials, planning for establishment of 
pharmaceutical care, identifying the patients and assessment of patient satisfaction in control 
group. 
Phase II- includes identifying and following the patient, establishment of pharmaceutical care 
and then assessing the patient satisfaction in intervention group. 
Phase III- includes the analysis of data. 
Control group:  
 Random selection of the sample from general population. 
 Patients receive treatment in the hospital from general Oncology department care 
set up. 
Intervention group: 
 Random selection of the sample from general population. 
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 Along with general care set up in hospital, patient also receives pharmaceutical 
care. 
Pharmaceutical care is given to the intervention group once the identification of patients is done 
and the assessment of satisfaction was done in both control and intervention groups. 
ESTABLISHMENT OF PHARMACEUTICAL CARE 
Establishment of Pharmaceutical care is primarily the initiation of services from the basic 
level by introducing the pharmacist to the clinical setup in a systematically planned approach to 
bring beneficial outcome for the patients. Further development on the same area will lead to 
complete establishment in an organized structure. Pharmaceutical care describes specific 
activities and services through which an individual pharmacist co-operates with a patient and 
other health professionals  to promote health, prevent disease and to assess, initiate and monitor 
medication use to ensure that drug therapy regimens are effective and safe aiming at patient’s 
health related quality of life and positive clinical outcomes. The following services are focused 
under pharmaceutical care in this study.  
 Patient Counselling:  
Patients are counseled regarding their disease, treatment, prevention and management, life style 
modifications. 
 Counselling on disease: The patients are informed about the present condition and 
relevance of continuing the treatment without fail pertaining to the different stages and 
specificity of disease. e.g., locally advanced disease, metastatic disease. 
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 Counselling on treatment: The patients being considered as the benefiter of the care plan, 
they are informed about the choices of treatments, course of therapy and importance of 
chemotherapy than other complementary treatments. 
 Counselling on drugs: The patients are informed about the dose, usage, possible side 
effects, detection and management of commonly seen side effects and the warning 
symptoms to be reported immediately.  
 Counselling on life style: The patients are informed about dietary modifications, exercise 
and drug-disease related changes and measures to overcome those to cope up with the 
treatment modalities. 
Out of four sections of counseling, each said to possess 25% to achieve absolute establishment of 
this area. The four sections considered to be the part of complete patient counseling are  
1) Pre-counseling -25% 
2) Counseling during the treatment -25% 
3) Counselling while discharge -25% 
4) Distribution of handwritten or printed leaflet -25% 
Pre-counselling is the counselling given on the day of diagnosis or before treatment as part of 
informing the choices of cost based therapies, course of therapy and the relevance to continue 
with the treatment without fail. Counselling during the treatment includes the details about drugs, 
its side effects, methods to manage and prevent the side effects etc. Counselling while discharge 
deals with the handling and administration of discharge medications along with the life style and 
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dietary modifications. Distribution of a handwritten or printed information leaflets make the 
counselling effective with improved information recalls by the patients.  
 PIL  
Preparation of the information leaflet is done according to the information needs shown by the 
patients, reviewing the treatment protocols and considering the common side effects of 
chemotherapy. Two steps coming under PIL are: 
1) Preparation of PIL  -    50%  
2) Distribution of PIL   -   50% 
The other services like dose calculation, pharmacist interventions, ADR monitoring and 
chemotherapy mixing are not focused since the establishment need much time and people to 
deliver the services promptly. 
ASSESSMENT OF PATIENT SATISFACTION 
Patient Satisfaction is a subjective and evaluative assessment that is derived from their 
expectations, needs, past experiences, opinion and attitudes.  It is a key indicator of quality of 
life. 
The questionnaire was distributed among the patients of both group and the filling is done in the 
presence of pharmacist.  
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Assessment parameters for patient satisfaction 
AGE :- Adult age was classified to three groups. 
 Young adults : 18-35 years 
 Middle-aged adults : 36-55 years 
 Older adults : Above 55 years 
No patients  under the age of 18 are  there in the study. 
 EDUCATION :- Level of education was classified to two groups. 
 Educated: Graduates and higher university degree holders. 
 Not educated: Those who got a school level and no formal education. 
                   The whole set of questions of Part III was further divided to 4 subsets for the 
assessment of patient satisfaction. Satisfaction score ranges from 0 to 5 and average mean value 
will be taken for calculation. 
Subset 1: - about Cancer treatment 
 3/15 questions 
 It includes Question No.1, 4 and 9. 
Subset 2:- about Side effects  
 4/15 questions 
 It includes Question No.2,  3, 5 and 10  
Subset 3:- about Complementary treatment options and drug use 
 4/15 questions 
  It includes Question No.6, 7, 8 and 11  
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Subset 4:- about information sources and how the information was presented. 
 4/15 questions 
  Question No.12, 13, 14 and 15 comes under subset 4 
Overall: - about overall satisfaction with the information provided. 
 15/15 questions 
 It includes Question No.1 – 15   
Statistical Analysis 
Data entry was done using Microsoft Excel 2010 and  analysis was carried out by using SPSS® 
20.0 for Windows. The comparison of satisfaction scores between control and intervention 
groups were done by using one-way ANOVA and the relationship of age and education with the 
perceived satisfaction was performed using Multivariate Analysis of Variance (MANOVA). 
Limitations 
Pre-counselling is not performed in this study as an initial stage of establishment, at present there 
is no provision to interfere with treatment plan directly and to prior inform patient about the 
course of therapy that even can decide if they want to continue or not. 
Preparation of PIL is designed in a common way regardless of the standard format that includes 
font, style, size, layout etc.  
PIL contain instructions and information in general to all type of cancer patients. So distribution 
of PIL is not done since the leaflet should be specific to a particular patient to avoid unnecessary 
anxiety among them. Direct access to patients is restricted at the present setup and thus the 
selection of sample was determined by the physician.               
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5. RESULTS  
Out of 119 patients in the total study population, control group consists of 60 patients and 
intervention group consists of 59 patients. 
Age wise distribution 
Most of the cancer cases fall in the age group of 40-60, having 67 patients in this age group 
followed by 36 patients in the age group of 60-79. Age distribution is almost similar in both 
control and intervention group. (Table 2 & Figure 1) 
Gender wise distribution 
Out of total patients, the predominance of patients receiving chemotherapy were male     
58.82 %, (N=70) and female were only 41.17%, ( N= 49). (Table 3 & Figure 2) 
Type of Cancer 
Among solid tumors, breast cancer (35) was the most common diagnosis in our study 
population, followed by lung and then rectal cancer. (Table 4 & Figure 3) 
Level of Education 
In our study population, majority of patients (53%) were school educated, 39% had college 
education and only 8% were illiterate (Table 5 & Figure 4). 
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 Adverse Drug Reactions 
There were 14 types of adverse reactions documented in which predominant types consisted 
of nausea/vomiting (41), hyperpigmentation (29), myalgia (22) and mucositis.(20)  (Table 8 
& Figure 7),Figure 7 (a) shows the number of adverse reactions on affected body systems. 
The four body systems were central nervous system, dermatologic, gastro intestinal and 
musculoskeletal. 
Establishment of Pharmaceutical Care 
Patient counseling (50%) was given to the intervention group (n=59). and based on our 
findings about the common adverse reactions we have developed patient information leaflet 
to manage side effects of chemotherapy, PIL preparation (50%). (Table 6 & Figure 5) 
1. Patient Counselling 
Out of 119 patients, 59 patients in intervention group were given patient counseling. Among 
the four sections of patient counseling, counselling during the treatment (25%) and 
counselling while discharge (25%) were given to patients whereas pre-counseling (0%) and 
distribution of handwritten or printed information leaflet (0%) were not given.  
2. Patient Information Leaflet  
A general information leaflet for cancer patients undergoing chemotherapy (Annexure III) 
was prepared (50%) on the basis of data collected form the study. But the distribution of 
leaflet was not achieved (0%)and thus it can also be considered as partial fulfillment of the 
plan. 
ASSESSMENT OF PATIENT SATISFACTION  
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A total of 60 questionnaires were collected from the control group and 59 questionnaires 
from the intervention group. The majority of patients were satisfied with the information 
given on cancer treatment in both the groups. The subset evaluation elucidated the differences 
in satisfaction between several information areas and overall satisfaction as a superior 
measure. Patient satisfaction with information was significantly improved upon 
pharmaceutical care. Subset 1 achieved a mean score of 4.25 in intervention group and was 
only 4 in control group (p=0.008). The mean score for Subset 2 was found to be significantly 
increased from 2.50 in control group to 4.19(p=0.000) in intervention group. Subset 3 
attained a  score of 3.24 in intervention group from 2.07(p=0.000) in control group. Subset 4 
assessing satisfaction with information sources and the way counseling presented attained a 
score of 4.15 in control group and 4.36(0.021) in intervention group. Overall satisfaction was 
significantly improved from a mean score of 3.04 in control group to 4.12 (p=0.000)in 
intervention group.(Table 9, Figure 8 and Table 12) 
Satisfaction Assessment based on Age and Education 
Overall satisfaction among the three age groups in control population is 2.67, 2.97 and 3.23 
in young adults, middle-aged adults and older adults respectively. The satisfaction scores 
given by the intervention population is improved to 4.14, 4.29 and 3.96 (p=0.000) by the 
respective age groups. Subset 1 control group scores are 4.17, 3.97 and 4.00 in young, middle 
aged and older adults respectively and the scores in intervention population are 4.43,4.38 and 
4.11 in the same age groups. In Subset 2, control population gave the mean scores of 2.50, 
2.30 and 2.75 in young, middle-aged and older adults. Whereas the intervention population 
showed a significant higher scores of 4.29, 4.33 and 4.04 (p=0.007) in the respective age 
group. Subset 3 scores in control group are 2.17, 1.87 and 2.29 and the scores have improved 
to 2.71, 3.13 and 3.46 in the respective age groups in intervention population. Subset 4 gives 
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2.67(control) to 4.14(intervention), 4.20(control) to 4.46(intervention) and 4.04(control) to 
4.29(intervention) by young, middle-aged and older adults respectively.( Table 10, Figure 
9(a) and 9(b), Table 13.(b)) 
 
Education wise satisfaction assessment 
Overall, both the educated and not educated groups showed almost similar scores.3.04 and 
3.09 in control group has improved to 4.19 and 4.08 in intervention group. This means both 
educated and not educated group patients are satisfied upon establishment of pharmaceutical 
care and shows our counselling is aptly applicable to educated and not educated group as 
well. On Subset 1 evaluation, both educated and not educated groups shows mean scores of 
3.96 and 4.03 in control population to 4.24 and 4.26 in intervention population in respective 
educated and not educated groups.. Subset 2 scores show values of 2.50 in control and 4.14 
in intervention by educated group and 2.50 in control and 4.14 in intervention population by 
not educated group. The satisfaction is significant in intervention group.(p=0.021). Subset 3 
evaluation shows the control population of educated and not educated group scores of 1.88 
and 2.21. In intervention groups the scores of 2.86 and 3.45 given by the respective 
education level groups.. Subset 4 mean scores of control population educated and not 
educated groups are 4.23 and 4.09 and 4.43 and 4.32 by the intervention population  
respectively. (Table 11, Figure 10(a) &(b), Table 13(b)) 
Information Sources 
Patients utilize their oncologist as the source of information in maximum number .of cases. 
Internet and others including family relatives, friends are the second choice for information 
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sources. In control group pharmacists were not identified as a resource person (0%).But in 
pharmaceutical care intervention group, participants started identifying the service of 
pharmacist as their information source (41%) after repeated conversations and counselling 
sections.(Table 7 & Figure 6).                           
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5. TABLES AND GRAPHS 
TABLE 1. CHARACTERISTICS OF THE TOTAL STUDY POPULATION 
 Control 
(n=60) 
Intervention 
(n=59) 
Average Age 52.64±3.56 52.67±3.31 
Gender   
       Male  
       Female 
35 
25 
36 
24 
Education 
       Educated 
       Not educated 
 
26 
34 
 
21 
38 
Type of cancer 
       Breast Cancer 
       Lung Cancer 
       Rectal Cancer  
       Colon Cancer 
       Oesophageal Cancer 
Prostate Cancer 
       Ovarian Cancer 
       Others 
 
19 
9 
6 
3 
3 
2 
1 
15 
 
16 
8 
4 
3 
3 
2 
3 
18 
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TABLE 2: AGE-WISE DISTRIBUTION IN CONTROL AND INTERVENTION GROUP 
Age Control 
(n=60) 
Intervention 
(n=59) 
Below 20 0 0 
20-39 8 9 
40-59 37 30 
Above 59 15 20 
 
 
FIGURE 1:AGE-WISE DISTRIBUTION IN CONTROL AND INTERVENTION GROUP 
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TABLE 3: GENDER-WISE DISTRIBUTION IN STUDY POPULATION 
 
Gender Control 
(n=60) 
Intervention 
(n=59) 
Total 
(n=119) 
Male 35 36 70 
Female 25 24 49 
 
 
 
FIGURE 2: GENDER-WISE DISTRIBUTION IN STUDY POPULATION 
 
 
 
 
  Tables and Graphs 
 
 
 
Page 31 
 
TABLE 4: DIAGNOSIS IN CONTROL AND INTERVENTION GROUP 
 
Type of Cancer Control 
(n=60) 
Intervention 
(n=59) 
Breast 19 16 
Cervix 2 2 
Colon 3 3 
Lung 9 8 
Rectal 6 4 
Oesophageal 3 3 
Ovary 1 3 
Prostate 2 2 
Ewing’s Sarcoma 1 4 
Others 14 14 
 
FIGURE 3: SHOWS THE TYPE OF CANCER IN STUDY POPULATION                
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TABLE 5: LEVEL OF EDUCATION IN TOTAL STUDY POPULATION 
 
Level of Education No. of Population Percentage (%) 
Illiterate 9 8 
School 63 53 
College 47 39 
 
 
FIGURE 4: SHOWS LEVELS OF EDUCATION AMONG STUDY POPULATION 
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TABLE 6: ESTABLISHMENT OF PHARMACEUTICAL CARE 
 
FIGURE 5: SHOWS THE DETAILS OF ESTABLISHMENT OF PHARMACEUTICAL 
CARE  
 
ELEMENTS OF PHARMACEUTICAL CARE PERCENTAGE OF 
ESTABLISHMENT (%) 
Patient Counselling 
1.Pre counselling 
2.During the treatment 
3.Discharge medication 
4.Handwritten or printed leaflet 
50 
0 
25 
25 
0 
Patient Information Leaflet 
1.Preparation 
2.Distribution 
50 
50 
0 
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TABLE 7: INFORMATION SOURCES USED BY THE STUDY POPULATION IN 
BOTH GROUPS 
Information Sources Control 
(n=60) 
Intervention 
(n=59) 
Oncologist 60 59 
Nurse 12 14 
Pharmacist 0 24 
Books 4 3 
Internet 21 18 
Others 14 9 
 
FIGURE 6: SHOWS INFORMATION SOURCES USED BY THE STUDY 
POPULATION IN BOTH GROUPS. 
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TABLE 8: ADVERSE DRUG REACTIONS IN TOTAL POPULATION 
 
Adverse Drug Reactions No. of Population 
Diarrhoea 20 
Constipation 18 
Lack of Appetite 13 
Mucositis 20 
PPE 8 
Hyperpigmentation 29 
Extravasation 12 
Onycholysis 10 
Nausea/Vomiting 41 
Neuropathy 13 
Hiccups 11 
Myalgia 22 
Leg Cramps 8 
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FIGURE 7: ADVERSE REACTIONS IN STUDY POPULATION 
 
FIGURE 7 (a): SHOWS ADVERSE REACTIONS AFFECTED BODY SYSTEM 
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TABLE 9: PATIENT SATISFACTION SCORES ON OVERALL AND SUBSET 
EVALUATION IN CONNROL AND INTERVENTION GROUP 
Groups Control 
(n=60) 
Intervention 
(n=59) 
Ca treatment(Subset 1) 4 4.25 
Side effects (Subset 2) 2.50 4.19 
Complementary 
treatment (Subset 3) 
2.07 3.24 
  Information presented 
(Subset 4) 
4.15 4.36 
Overall 3.04 4.12 
 
 
FIGURE 8: SHOWS PATIENT SATISFACTION SCORES ON OVERALL AND 
SUBSET EVALUATION 
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TABLE 10 :  AGE VERSUS SATISFACTION SCORES IN BOTH GROUPS 
 
Age 
 
Variables 
 
Control 
(n=60) 
 
Intervention 
(n=59) 
 
Young adults 
Cancer treatment 4.17 4.43 
Side effects 2.50 4.29 
Complementary treatment 2.17 2.71 
Information presented 4.33 4.29 
Overall 2.67 4.14 
 
Middle-aged adults 
Cancer treatment 3.97 4.38 
Side effects 2.30 4.33 
Complementary treatment 1.87 3.13 
Information presented 4.20 4.46 
Overall 2.97 4.29 
          
Older adults 
Cancer treatment 4.00 4.11 
Side effects 2.75 4.04 
Complementary treatment 2.29 3.46 
Information presented 4.04 4.29 
Overall 3.23 3.96 
 
 
 
 
  Tables and Graphs 
 
 
 
Page 39 
 
FIGURE 9 (a): SHOWS AGE VERSUS SATISFACTION SCORES IN CONTROL 
GROUP 
 
  
FIGURE 9 (b) : SHOWS  AGE VERSUS SATISFACTION SCORES IN INTERVENTION 
GROUP  
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      TABLE 11. EDUCATION VERSUS SATISFACTION SCORES IN BOTH GROUPS 
 
 
 
 
 
 
 
 
Education 
 
Variables 
 
 
Control 
(n=60) 
 
Intervention 
(n=59) 
 
 
Educated 
 
Cancer treatment 3.96 4.24 
Side effects 2.50 4.14 
Complementary 
treatment 
1.88 2.86 
Information presented 4.23 4.43 
Overall 3.08 4.19 
 
 
Not Educated 
Cancer treatment 4.03 4.26 
Side effects 2.50 4.21 
Complementary 
treatment 
2.21 3.45 
Information presented 4.09 4.32 
Overall 3.09 4.08 
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FIGURE 10(a): SHOWS EDUCATION VERSUS SATISFACTION SCORES IN 
CONTROL GROUP 
 
 
 
FIGURE 10(b): SHOWS THE EDUCATION VERSUS SATISFACTION SCORES IN 
INTERVENTION GROUP 
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TABLE 12: SUBSET AND OVERALL ANALYSIS OF SATISFACTION IN CONTROL  
AND INTERVENTION GROUP 
 
One Way ANOVA:  
 
ANOVA 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
Cancer treatment Between 
Groups 
1.923 1 1.923 7.214 .008 
Within 
Groups 
31.186 117 .267   
Total 33.109 118    
Side effects Between 
Groups 
84.605 1 84.605 190.549 .000 
Within 
Groups 
51.949 117 .444   
Total 136.555 118    
Complementary  
Treatment 
Between 
Groups 
40.765 1 40.765 40.279 .000 
Within 
Groups 
118.411 117 1.012   
Total 159.176 118    
Information 
presented 
Between 
Groups 
1.262 1 1.262 5.431 .021 
Within 
Groups 
27.175 117 .232   
Total 28.437 118    
Overall Between 
Groups 
34.504 1 34.504 64.783 .000 
Within 
Groups 
62.315 117 .533   
Total 96.819 118    
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TABLE 13: ASSESSMENT OF AGE AND EDUCATION WISE SATISFACTION IN BOTH GROUPS 
a.   Between Subject Factors 
 
 
 
 
 
 
b. Multivariate Analysis   
 
 Value Label N 
Group 1 Control 60 
2 Intervention 59 
Age 1 young adults 13 
2 middle-aged 
adults 
54 
3 older adults 52 
Education 1 Not educated 72 
2 Educated 47 
Source Dependent Variable Type III Sum of 
Squares 
df Mean Square F Sig. 
Group * Age Cancer treatment .932 2 .466 1.813 .168 
Side effects 4.385 2 2.192 5.239 .007 
Complementary  1.651 2 .826 .845 .432 
Information presented .027 2 .014 .057 .945 
Overall 4.285 2 2.143 4.088 .019 
Group * 
Education 
Cancer treatment .584 1 .584 2.269 .135 
Side effects 2.307 1 2.307 5.513 .021 
Complementary .486 1 .486 .497 .482 
Information presented .078 1 .078 .323 .571 
Overall 1.619 1 1.619 3.089 .082 
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6. DISCUSSION 
The prospective interventional study was aimed to assess the patient satisfaction on treatment 
education upon establishment of pharmaceutical care in oncology. 
                 Cancers are mainly occurring in the age group of 40-60 years, showing 67 patients 
in this age group followed by 35 patients in the age group of 60-70 years. These results 
obtained in our study was similar to the results obtained by the study conducted by 
Ganjewala D (2009) in Madhya Pradesh during April,2005, in which 51% patients fell in the 
age group of 50-75%, followed by 41% in age group of 25-50 years and 8% in 0-25 years.
36
  
  Based on our study, the predominance of patients receiving chemotherapy were 
men (58.82%, N=70) and female cancer patients were only 41.17%. These results 
reciprocates the result of study conducted by Zekb A et al.,(2008) in Pakistan during  the 
period of 2000-2004, in which out of 1105 cancer patients, 62% were males and 38% were 
females 
37
. 
                   In a study conducted by Matsuyama RK, et al., showed, out of 138 patients, 36 
patients were diagnosed with lung cancer, 33 diagnosed as gastro intestinal and the follower 
by 32 patients with breast cancer. Whereas in our study out of 119 patients,35 patients were 
diagnosed with breast cancer followed by 22 with gastro intestinal and 17 with lung cancer
38
. 
                 Level of education plays a role in the understanding of information given while 
counseling. Those with comparatively low level of education showed a higher demand for 
information on chemotherapy. Among 119 patients of the study, 53 % had completed a 
school level of education, 39 % completed college level education and only 8% were found to 
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be illiterate.  These results are similar to the study conducted by Matsuyama RK et 
al.(2011). Over half the sample had completed education above high school while 25% had 
attained only a high school diploma or General Education Diploma (GED).  23% had less 
than high school
38
. 
                  Adverse drug reactions are monitored and documented in the study as a part of 
pharmaceutical service and out of total patients, predominant type of adverse effect consisted 
of nausea/vomiting(41) hyperpigmentation (29), myalgia (22) and mucositis (20) and 
diarrhoea (20). These results are similar to the study conducted by Ruder AD et.al.,(2010) 
who conducted a retrospective descriptive analysis of clinical interventions by the oncology 
pharmacist. Out of 131 adverse events documented by the pharmacist, the predominant types 
of adverse events consisted of nausea/vomiting (23), rash (21), diarrhoea (17), and myalgia 
(15)
17
. 
Patient Satisfaction Assessment 
a. Overall satisfaction 
Overall satisfaction measures all the 15 questions in the questionnaire. In control group, the 
average mean score was 3.04 and in intervention group it improved to 4.12. (p=0.000). The 
significant increase in the intervention group is suggestive to highlight the positive influence 
of pharmaceutical care. The scores could be maximized in several areas by considering the 
information needs and demands of the patients. 
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b. Subset 1 
In the first subset which measures the satisfaction for cancer treatment information, 
control group has given a mean score of 4 and 4.25 (p=0.008)is given by the intervention 
group. This indicates there is already a better care set up receiving information educaton 
about cancer treatment in the hospital. Along with the general set up, our additional 
counseling sections improved their satisfaction significantly. 
c. Subset 2 
Second subset that covers the questions about side effects and its management was an 
area which appreciably showed a very good response in intervention group. The score 
was improved from 2.50 (control) to 4.19 (intervention) (p=0.000). A detailed 
informative discussion session about side effects and its management shows a significant 
improvement in the intervention group thereby enabling the patients to manage their side 
effects.  
d. Subset 3 
Evaluation of subset 3 about complementary treatment options gives a mean score of 2.07 
in control group and 3.24 in intervention group. It clearly shows that the patients are 
poorly satisfied and discussion on this area was not encouraged as the score is too low in 
the control group. From the intervention group satisfaction level was significantly 
improved (p=0.000) and they are somehow satisfied with the pharmacist given patient 
counseling. Still this area needs to be concentrated to achieve maximum level of 
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satisfaction by discussing various aspects, benefits and risks clearly about the 
complementary treatment options. 
e. Subset 4 
How information is delivered to the patient has an important impact in the understanding 
and perceived satisfaction. The score in control group is 4.15 and in the intervention 
group it shows improvement to 4.36 (p=0.021). This indicates in both group patients were 
well satisfied and received the information in a clear, easily understandable manner. But 
in addition, the individual approach given by the pharmacist to the intervention group has 
got improved satisfaction from the patients. 
Age wise satisfaction assessment 
Overall satisfaction among the three age groups in control population is 2.67, 2.97 and 
3.23 in young adults, middle-aged adults and older adults respectively. The satisfaction 
scores given by the intervention population is improved to 4.14, 4.29 and 3.96 by the 
respective age groups which shows the improved satisfaction level is statistically 
significant (p=0.019). This shows that the counselling given was well satisfied by the 
intervention population in all the three age groups. Subset 1 was also well satisfied by the 
all the three age groups (4.17, 3.97 and 4.00) in young, middle aged and older adults of 
control population respectively. The scores in intervention population are 4.43,4.38 and 
4.11 in d same age groups respectively. Scores are not significant but still we can observe 
the improvement on satisfaction level in intervention group. In Subset 2, control 
population gave the mean scores of 2.50, 2.30 and 2.75 in young, middle-aged and older 
adults. Whereas the intervention population showed a significant higher scores of 4.29, 
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4.33 and 4.04 (p=0.007) in the respective age group. In spite of the difference in age our 
counselling concentrating on the various aspects of side effects and detailed information 
has shown an appreciable improvement and the patients are well satisfied. Subset 3 scores 
in control group are 2.17, 1.87 and 2.29 and the patients are poorly satisfied with 
information on complementary treatment options. Upon counselling the intervention 
population the scores have improved to 2.71,3.13 and 3.46 in the respective age groups. 
Statistically the satisfactory scores are not significant. Still we can observe the 
improvement in intervention group. Subset 4 gives 2.67(control) to 4.14(intervention), 
4.20(control) to 4.46(intervention) and 4.04(control) to 4.29(intervention) by young, 
middle-aged and older adults respectively. The patients are well satisfied in intervention 
group but it can be improved still to maximize the satisfaction level. 
Education wise satisfaction assessment 
Overall, both the educated and not educated groups showed almost similar scores.3.04 
and 3.09 in control group has improved to 4.19 and 4.08 in intervention group. This 
means both educated and not educated group patients are satisfied upon establishment of 
pharmaceutical care and shows our counselling is aptly applicable to educated and not 
educated group as well. On Subset 1 evaluation, both educated and not educated groups 
shows mean scores of 3.96 and 4.03 in control population to 4.24 and 4.26 in intervention 
population in respective educated and not educated groups. Improvement is slight but yet 
observable from the satisfaction scores in intervention group. Subset 2 scores show values 
of 2.50 in control and 4.14 in intervention by educated group and 2.50 in control and 4.14 
in intervention population by not educated group. The satisfaction is significant in 
intervention group.(p=0.021).In spite of education our counselling was effective in both 
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the education level groups which gave an appreciable improvement of satisfaction level. 
On subset 3 evaluation, control population of educated and not educated group showed 
the mean scores of 1.88 and 2.21.Coming to the intervention group we can observe the 
increased scores of 2.86 and 3.45 by the respective education level groups. Satisfaction is   
improved, but yet to be focused in this area to enhance the satisfaction level. Subset 4 
mean satisfactory scores of control population educated and not educated groups are 4.23 
and 4.09 which upon intervention by pharmacist improved to 4.43 and 4.32 by the 
education level group respectively.  
                  In a study conducted in Germany by  Liekwig A et al., (2012), the patient 
received education on cancer treatment as part of pharmaceutical care implementation. The 
study population was divided into control group (N= 48) as those receiving conventional 
chemotherapy education and pharmaceutical care intervention group (N=50). In a similar way 
our study included 60 patients in control group and 59 patients in intervention group for 
whom patient counseling was given to improve the medication adherence of patients. They 
have also performed patient satisfaction assessment with cancer treatment education on both 
the groups. The global satisfaction score and the subscale analysis showed a statistically 
significant improvement from control group to intervention group except for the 
complementary treatment options. Median scores of 4.0,4.0,4.0, 3.9 in control group was 
improved to 4.4,4.3,4.2,4.5,4.4 in intervention group for subscale analysis of satisfaction with 
information provided on cancer treatment, side effects, complementary treatment options, 
information sources and global satisfaction respectively. Similar way In  our study, the results 
shows statistically significant in Subset 1, 2, 3, 4 and overall. The satisfaction scores obtained 
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in our study for control group are 4, 2. 50, 2.07, 4.15   and 3.04 whereas 4.25, 4.19, 3.24, 4.36 
and 4.12 in the intervention group for the respective subsets and overall value
39
.                   
                 The information sources used by the patients were examined to know the 
recognition of pharmacist among the population. In both the groups, oncologist was the main 
resource person. Control group patients didn’t consider pharmacist as their information 
source at all which clearly shows there have been no previous pharmacist services established 
under pharmaceutical care in the hospital. 41% of pharmaceutical care intervention group 
found pharmacist also as their information source in our study. Similar way, Liekweg  et.al, 
conducted a sequential study in Germany to develop a questionnaire measuring patient 
satisfaction with treatment education for cancer patients.. Pharmacist seemed to play a minor 
role as source of information in the pretest and main test groups
14.
  
                  Age was considered to play a role in perceiving satisfaction. In our study, age 
showed significant satisfactory scores on overall assessment (p=0.019) and subset 2 
regarding side effects (p=0.007). As per the study conducted by Walker et.al.,(1999), patient 
satisfaction was predicted by younger age
40
. Education of patient has also got an impact on 
satisfactory scores. In a study conducted by Rahmqvist et.al., in Sweden, patient 
characteristics and quality dimensions related to patient satisfaction was examined and the 
results showed that those with less education are more satisfied than the patients with more 
education.  Whereas in our study educated and not educated group showed almost similar 
satisfaction scores
41.
.  
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Obstacles 
 Awareness on pharmaceutical services among patients and other health care 
professionals is very low. 
As the clinical pharmacist is exposed for the first time to the patient, unwillingness   to 
cooperate and to disclose their actual underlying problems and opinions should be considered 
as the failure of effective pharmaceutical care services. 
 Direct patient-staff relationship 
Most of the cases observed show a good satisfaction for general care set up (control group) 
and they don’t prefer any change from the general care by an additional care group showing 
reluctance to reveal the actual information need of patient. 
 Lack of knowledge on psychological support 
 Cancer patients demand lots of psychological support. Lack of knowledge to handle the 
difficult situations is faced while approaching individual patients.  
 Lack of communication provisions with the healthcare professionals 
Access to oncologist and other health professionals was not always easier and  consume 
enough time. 
 Lack of professionals 
As the continuous day and night hours are necessary to give complete pharmaceutical care for 
individual patient, lack of personnel in the pharmacy department could be considered as a 
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major drawback because lack of supervision on, mixing, administration and monitoring for 
adverse reactions and reporting should be handled from the point of admission till discharge 
for every individual patient receiving chemotherapy. 
             
 
 
  Conclusion 
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6. CONCLUSION 
                      In conclusion, our results suggest that patients seem to show good response 
with satisfaction towards patient counselling upon pharmaceutical care in oncology. Patient 
satisfaction is beneficial to improve patients’ quality of life, thereby leading to achieve 
positive clinical outcome. 
                      Currently, patients are well satisfied about cancer treatment information with 
the general set up. But the introduction of pharmaceutical care could still improve the level of 
satisfaction to maximize the clinical benefits. The counseling on complementary treatments 
is yet to be improved as most of the patients are somehow satisfied with the information 
given about that. Different age groups and education levels show difference in satisfaction 
level and our way of approach should be set in that way to bring considerable improvement 
for all of them. A need based information education is always preferable to satisfy all kind of 
patients. We found significant progress with higher satisfaction upon knowledge on side 
effects and its management by the establishment of pharmaceutical care. This knowledge will 
improve patient compliance and enables then to cope up with further treatment modalities.  
                      Identifying the pharmacist by the patient is the first step of progress from which 
pharmaceutical care services can grow further. At present, the profession of oncology 
pharmacist is at a very low level and scarcely identified by patient. Similar studies 
concentrating on various areas of pharmaceutical care can improve the profession as well as 
patients’ outcome.   .  
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Recommendations 
  
 
 
RECOMMENDATIONS 
1.  Awareness on importance of pharmaceutical services among patients and other 
healthcare providers should be created. 
2.  Relationship between a pharmacist and a patient should develop to assure them that 
they can also contribute to their beneficial health status. 
3.  Practical learning methods for patient counselling should include emotional and   
psychological aspects also. 
4.  Responsibilities of pharmacist are more and currently not in an authentic position. 
This situation must change and should start involve in direct plan for patient.  
 
1 
 
Patient Satisfaction with Cancer Treatment Education Questionnaire 
 
Part I 
This part of the questionnaire deals with general data. 
1) Age in years: 
2) Gender  
                    Female          Male 
3) Marital Status  
                   Married           Unmarried            Widowed 
4) Current living Situation 
                    Living alone        Living with Family       Living in institution 
                                                                                        (e.g., nursing home/care home) 
5) Education  
      No Formal Education               School 
      Graduate          Higher University degree  
 
6) Occupation 
      
        Employed                     Business            Pensioner 
        Housewife                    Student             Workers 
        Others 
 
7) I know of my illness                           
a.   Time since:                 
b.          Hospitalised         In  Outpatient treatment at oncologist 
             Inpatient treatment at hospital oncologist                                               
 
8) I am in an active support group. 
     Yes          No 
 
 
 
   
2 
 
Part II 
Please briefly answer a few questions about the sources of 
information you use. 
1. What or who is currently your main source of information about your treatment? 
(Please tick all options that apply to you) 
       Doctor          Nurse          Pharmacist           Internet    
       Books            Others 
 
 
 
2. What or who was previously your main source of information about your treatment? 
(Please tick all options that apply to you) 
       Doctor          Nurse          Pharmacist           Internet    
       Books            Others 
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Part III 
Please tick any of the following statements on a number. It expresses how strong you are 
with the information to satisfaction.  
Please let us know your opinions about all the information with you to the present date. 
Place:                                                                                                                        Date: 
   
 
Strongly 
disagree  
(1) 
Disagree 
(2) 
Uncertain 
(3) 
Agree 
(4) 
Strongly 
agree 
(5) 
Not 
Specified 
 
1 
I am satisfied with the 
information I have been 
given about my cancer 
treatment. 
      
 
2 
I am satisfied with the 
information I have been 
given about possible side 
effects on my treatment. 
  
      
 
3 
I am satisfied with the 
information I have been 
given about what to do if 
side effects happen. 
      
 
4 
I am satisfied that I get 
enough opportunity to ask 
questions about my cancer 
treatment 
      
 
5 
 I am satisfied that I get 
enough opportunity to ask 
questions about how to 
manage side effects 
. 
      
 
6 
I am satisfied that I get 
enough opportunity to ask 
questions about the use of 
drugs and complementary 
therapies. 
      
 
7 
I am satisfied with the 
answers to my questions 
about the use of drugs and 
complementary therapies. 
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  Strongly  
Disagree 
(1) 
Disagree 
(2) 
Uncertain 
(3) 
Agree 
(4) 
Strongly  
Agree 
(5) 
Not 
specified 
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 I am satisfied with the 
explanations about possible 
interactions between my 
prescribed cancer 
treatment and other 
treatments I amusing or 
thinking about using. 
      
 
9 
I am satisfied that I am able 
to make informed choices 
about my cancer treatment. 
      
 
10 
I am satisfied that I am able 
to make informed choices 
about how to manage side 
effects  
      
 
11 
I am satisfied that I am able 
to make informed choices 
about the use of drugs and 
complementary therapies 
      
 
12 
I am satisfied with the 
available information 
resources such as the hand-
outs and staff. 
 
      
13 I am satisfied with the 
instructions given about 
taking and handling of my 
medications. 
      
14 Overall, I am satisfied with 
the manner in which the 
information is provided. It is 
friendly, respectful and 
non-judgemental. 
      
15 I am satisfied with the way 
treatment information is 
presented to me. It is clear 
and easy to understand. 
      
                                                       
WE ARE GRATEFUL FOR ANY FURTHER COMMENTS AND SUGGESTIONS. 
THANK YOU FOR THE TIME YOU HAVE MADE HEREWITH.   
IT SERVES YOU AND OTHER PATIENTS. 
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DATA COLLECTION FORM 
 
Name of Patient:                                                                          Date of Admission:      
IP No:                                                                                              Date of Discharge: 
Age:                              Gender:                                                    Name of Consultant: 
Body Wt.:                     Height:  
 
Symptoms: 
 
 
 
Past Medical History: 
 
 
Past Medication History: 
 
 
 
Diagnostic Test: 
 
 
Diagnosis: 
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Drug Regimen 
CHEMOTHERAPY 
Date No Start 
Time 
    Drugs    IV Fluid Dose RoA End 
Time 
Duration 
         
         
         
         
         
         
 
SUPPORTIVE MEDICATIONS 
Date No      Drugs Dose RoA Time of  
Administration 
      
      
      
      
 
DISCHARGE MEDICATIONS 
No Drugs Dose RoA Frequency Duration 
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CHEMOTHERAPY AND YOU 
Chemotherapy aims primarily for the control of systemic spread of cancer cells. The drugs are 
most often injected into the bloodstream through an intravenous needle in your arm. Everyone 
reacts differently to chemotherapy and some people may have no side effects at all. Here we 
will see few commonly seen side effects and more importantly how to manage it during the 
complete course of treatment. 
No Possible Side effects How it may develop? How to manage it? 
1. Hair loss 
 
Mainly noted in the scalp hair; 
Other body hair is frequently 
lost. Typically begins after 2-3 
weeks of first chemotherapy 
treatment. Re-growth of hair 
usually begins 6-8 weeks after 
the completion of 
chemotherapy. 
1.Wearing wigs 
2.Using scarves or other head 
coverings 
2. Mouth sores and 
Sore throat 
Ulcers in the mouth, dryness of 
the mouth, pain, infection, 
bleeding and difficulty 
swallowing. 
1. Rinse your mouth with  
 A salt/soda solution (1 tsp. salt, 1  
tsp. baking soda, 1 glass of water).  
2. Use soft bristle tooth brush. 
3. Anaemia/Weakness Fatigue, headache, dizziness, 
tiredness, looking pale, racing 
heartbeat. 
Include iron rich food diet like green 
leafy vegetables, gooseberries, dry 
fruits etc. 
4. Nausea and  
Vomiting, 
Loss of appetite 
Usually begin on the day of 
treatment and can last 1-3 days 
after chemotherapy. 
1. Eat foods at room temperature. 
2. Eat 5-6 small frequent meals. 
3. Take a short walk before meals. 
4. Exercising may increase your  
appetite 
5. Infection Usually develops 7-14 days 
after chemotherapy. 
High temperature, shivering, 
cough, rashes and diarrhoea. 
1. Check your temperature and 
contact hospital if 100oF or more. 
2. Keep away from crowded places 
and people suffering from infections. 
 
 
 
GENERAL INSTRUCTIONS: 
 Drink 2 to 3 L of water daily. 
 Not to receive vaccination during treatment. 
 Use contraception (non hormonal) during treatment and 4-6 months after; Avoid breast 
feeding. 
 Avoid hazardous tasks, since confusion, dizziness may occur. 
 Avoid crowds to reduce the risk of infection. 
 Avoid use of OTC products with aspirin, ibuprofen and other NSAIDs. 
 Avoid spicy, heavily seasoned or citrus food. 
 
SPECIAL INSTRUCTIONS: 
If you have received the treatment with the following drugs, please note the additional 
instructions given below. 
1. Report hearing disturbances and ringing in the ears. 
            (CARBOPLATIN, CISPLATIN) 
2.  Report numbness, tingling sensation on face, fingers and toes. 
(PACLITAXEL, DOCETAXEL, OXALIPLATIN, CISPLATIN, CARBOPLATIN, 
VINBLASTINE, VINCRISTINE, IFOSFAMIDE) 
 
3. Use sunscreen or do not expose to direct sunlight. 
(5-FLUOROURACIL, METHOTREXATE, TAMOXIFEN, VINBLASTINE) 
 
4. Avoid exposure to hot water, contact with harsh chemicals like detergents, cleaning 
products and report redness, blisters, cracking and peeling of skin on hands and foot. 
(CAPECITABINE, 5-FLUOROURACIL, DOXORUBICIN) 
 
5. Report visual problems and unusual vaginal bleeding.  
(TAMOXIFEN) 
 
If you have any questions or need more information, please ask. Remember that health 
care professionals, family and friends can help during this time. Together we can help 
you find the best ways to cope with your chemotherapy treatment.  
Keep in mind that the following changes occur with particular treatment and will 
disappear after the course of therapy. 
 Pain in muscle and joints (DOCETAXEL, PACLITAXEL) 
 Urine and other body fluids may appear orange to red in colour for 2 days. 
(DOXORUBICIN, EPIRUBICIN) 
 Pruritus, vaginal bleeding and hot flushes (TAMOXIFEN) 
 Impotence and amenorrhea (CARBOPLATIN,CHLORAMBUCIL,CISPLATIN, 
CYCLOPHOSPHAMIDE) 
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INTRODUCTION 
• A cancer diagnosis places considerable stress on 
patients and their families. They find  themselves 
discomfort with the strange health system; making 
serious decisions with long term consequences; 
living with uncertainness about the nature, cause 
and indefinite progress of the disease1. 
• Pharmaceutical care is considered as a patient 
centered, outcome oriented pharmacy practice that 
requires the qualified pharmacist to work in 
concert with the patient and other health care 
provider 2 . 
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• „Patient perception of care‟ encompasses both patient 
satisfaction and their experience of care. Patient 
satisfaction is a subjective, evaluative assessment that 
is derived from expectations, needs, past experiences, 
opinions and attitudes3. 
• Patient satisfaction assessment has become an 
important tool for health care professionals to 
systematically measure patients‟ perceptions of care 4. 
• Cancer patients show a desire for maximum amount 
of information regarding their treatment, prefer open 
communication about their illness and displayed high 
levels of hope to develop coping strategies and to 
initiate self- care behavior 5. 
 
 
 
 
 
2/28/2014 4 
 
 
• At the other side, clinical role of pharmacist in 
oncology as well as in other departments remained 
neglected for years within India6. 
 
• Pharmaceutical care is initiated in the oncology 
department of our hospital to create a better 
experience for cancer patients by delivering patient 
centered care. As part of establishment of 
pharmaceutical care we utilize this study to 
contribute patient oriented services and also to find 
out the effectiveness of the service upon their 
satisfaction, thus show the importance of 
pharmaceutical service in clinical setup.  
      . 
 
 
 
2/28/2014 5 
MATERIALS & METHODS 
 A prospective interventional study on establishment 
of pharmaceutical care and its patient satisfaction 
assessment in a tertiary care hospital was initiated. 
 
Objective 
• Primary objective : Assessment of patient 
satisfaction on pharmaceutical care. 
• Secondary objective : Establishment of 
pharmaceutical care and improvement of quality 
of life. 
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Study Site: 
• We received Ethics Clearances from “KMCH 
ETHICS COMMITTEE” in order to conduct the 
study in Kovai Medical Center and Hospital, 
Coimbatore. 
Study Period:  
• The study was carried over a period from the 
month of May 2013 to February 2014. 
Study Population: 
Inclusion Criteria: 
• Patients diagnosed with cancer and admitted for 
chemotherapy. 
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• Patient selection determined by physician. 
• Patients from whom oral consent is received. 
Exclusion Criteria: 
     No special exclusion criteria. 
STUDY MATERIALS 
1. Modified-Patient Satisfaction with Cancer 
Treatment Education Questionnaire. (PS-CaTE) 
(Adopted from Canadian PS-CaTE questionnaire) 7. 
The questionnaire measures patients‟ satisfaction with 
the   information they received about  their  
chemotherapy. 
.  
 2/28/2014 8 
It consists of three parts 
• Part I - Sociodemographic characteristics of the 
patient. 
• Part II- Sources of information regarding 
chemotherapy utilized by the patients  
• Part III- Contains 15 questions that evaluates the 
patients‟ perception on the information given during 
their cancer treatment on a five point Likert scale. 
2.  Data Collection Form  
• This is the form used to collect individual details like 
name, age, gender, past medical history and medication 
and medication history, diagnosis, and chemotherapy. 
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Patient Information Leaflet (PIL)  
• Patient information leaflet consists of the information 
regarding the common side effects, the detection and the 
management of side effects along with general 
instructions to be followed by a patient receiving 
chemotherapy. 
Study Procedure 
• The whole study consists of three phases. 
 
• Phase I- includes the preparation of supportive materials, 
planning for establishment of pharmaceutical care, 
identifying the patients and assessment of patient 
satisfaction in control group. 
2/28/2014 10 
• Phase II- includes identifying and following the 
patient, establishment of pharmaceutical care and 
then assessing the patient satisfaction in intervention 
group. 
• Phase III- includes the analysis of data. 
Control group:  
• Random selection of the sample from general 
population and patients receive treatment in the 
hospital from general Oncology department care set 
up. 
Intervention group: 
• Along with general care set up in hospital, patient 
also receives pharmaceutical care. 
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Pharmacist 
given patient 
education 
General 
treatment 
education 
The following services are focused under pharmaceutical 
care in this study.  
Patient Counselling:  
• Patients are counseled regarding their disease, 
treatment, prevention and management, life style 
modifications. 
• Out of four sections of counselling, each said to 
possess 25% to achieve absolute establishment of this 
area. The four sections considered to be the part of 
complete patient counseling are:  
1. Pre-counseling -25% 
2.  Counseling during the treatment -25% 
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• Counselling while discharge -25% 
• Distribution of handwritten or printed leaflet-25% 
 Pre-counselling :counselling given on the day of   
diagnosis or before treatment as part of informing the 
choices of cost based therapies, course of therapy and 
the relevance to continue with the  treatment without 
fail.  
Counselling during the treatment : includes the details 
about drugs, its side effects, methods to manage and 
prevent the side effects etc.   
Counselling while discharge : deals with the handling 
and administration of discharge medications along 
with the life style and dietary modifications.   
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Distribution of a handwritten or printed information 
leaflets : make the counselling effective with improved 
information recalls by the patients. 
 
    PIL (Patient Information Leaflet) 
• Preparation of the information leaflet is done 
according to the information needs shown by the 
patients 
   Two steps under  PIL are: 
• Preparation of PIL  -    50%  
• Distribution of PIL   -   50% 
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The other services like dose calculation, ADR monitoring 
and chemotherapy mixing are not focussed since the 
establishment need much time and people to deliver the 
services promptly. 
Assessment parameters for patient satisfaction 
Age : Adult age was classified to three groups. 
• Young adults : 18-35 years 
• Middle-aged adults : 36-55 years 
• Older adults : Above 55 years 
Education : Level of education was classified to two 
groups. 
• Educated: Graduates and higher  degree holders. 
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The whole set of questions of Part III was further divided 
to 4 subsets for the assessment of patient satisfaction. 
Subset 1: - about cancer treatment 
Subset 2: -  about  side effects  
Subset 3: - about complementary treatment options 
Subset 4: - about the manner how information presented 
Overall: -  overall satisfaction with information  
                   provided 
Satisfaction scores for all subsets and overall ranges from 
0 to 5 and their average mean is taken for further 
calculation 
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Statistical Analysis 
 
• Data entry was carried out by using Microsoft Excel 
2010. and analysis was done by using SPSS® 20.0 for 
Windows The comparison of satisfaction scores 
between control and intervention groups were done by 
using one-way ANOVA and the assessment based on 
age and education with the perceived satisfaction was 
performed using Multivariate Analysis of Variance 
(MANOVA). 
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Limitations 
• Pre-counselling is not performed in this study as an 
initial stage of establishment, at present there is no 
provision to interfere with treatment plan directly and 
to prior inform patient about the course of therapy 
that even can decide if they want to continue or not. 
• Preparation of PIL is designed in a common way 
regardless of the standard format that includes font, 
style, size, layout etc.  
• Distribution of PIL is not done since the leaflet 
should be specific to a particular patient to avoid 
unnecessary anxiety among them. 
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RESULTS  
ASSESSMENT OF PATIENT SATISFACTION  
• A total of 60 questionnaires were collected from the 
control group and 59 questionnaires from the 
intervention group.  
• Patient satisfaction with information was significantly 
improved upon pharmaceutical care.  
• Subset 1 achieved  a mean score of 4.25 in intervention 
group and was only 4 in control group (p=0.008).  
• The mean score for Subset 2 was found to be 
significantly increased from 2.50 in control group to 
4.19(p=0.000) in intervention group. 
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• Subset 3 attained a  score of 3.24 in intervention 
group from 2.07(p=0.000) in control group.  
• Subset 4 assessing attained a score of 4.15 in 
control group and 4.36(0.021) in intervention 
group.  
• Overall satisfaction was significantly improved 
from a mean score of 3.04 in control group to 4.12 
(p=0.000)in intervention group.(Table 8, Figure 8 
and Table 13) 
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Age and education upon perceived patient satisfaction 
•  In intervention population all the age group reported 
significantly higher satisfaction on information 
provided about side effects (Subset 2) (p= 0.007) and 
in overall (p=0.019) . 
•  In all the other categories of Subset 1, 3, and 4 the 
age didn‟t show any significant result on satisfactory 
scores. (Table 9,10, 16 & Figure 9 &10).  
• Both educated and not educated group of patients was 
found to be highly satisfied whit Subset 2 (p=0.021). 
(Table 11,12, 16 & Figure11 & 12). 
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Information Sources 
• Patients utilize their oncologist as the source of 
information in maximum number of cases.  
• Internet and others including family relatives, friends 
are the second choice for information sources. 
• In control group pharmacists were not identified as a 
resource person (0%). 
• But in pharmaceutical care intervention group, 
participants started identifying the service of 
pharmacist as their information source (41%) after 
repeated conversations and counselling 
sections.(Table 6 & Figure 6). 
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Establishment of Pharmaceutical Care 
1. Patient Counselling (50%) 
• Out of 119 patients, 59 patients in intervention group 
were given patient counseling. Among the four sections 
of patient counseling, counselling during the treatment 
(25%) and counselling while discharge (25%) were 
given to patients whereas pre-counseling (0%) and 
distribution of  information leaflet (0%) were not given.  
2. Patient Information Leaflet (50%) 
• A general information leaflet for cancer patients 
receiving chemotherapy (Annexure III) was prepared 
(50%)on the basis of data collected form the study. But 
the distribution of leaflet (0%)was not done. 
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TABLE 1 : AGE- WISE DISTRIBUTION IN CONTROL AND 
INTERVENTION GROUPS 
FIGURE 1 :  AGE- WISE 
DISTRIUTION AMONG STUDY 
POPULATION 
Age Control 
(n=60) 
Intervention 
(n=59) 
Below 
20 
0 0 
20-39 8 9 
40-59 37 30 
Above 
59 
15 20 
TABLES AND GRAPHS 
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Gender Control 
(n=60) 
Intervention 
(n=59) 
Total 
Male 35 35 70 
Female 25 24 49 
TABLE 2: GENDER-WISE DISTRIBUTION IN STUDY POPULATION 
 
FIGURE 2: GENDER-WISE 
DISTRIBUTION IN STUDY 
POPULATION 
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TABLE 3: DIAGNOSIS IN STUDY POPULATION 
 
FIGURE 3: SHOWS THE TYPE OF 
CANCER IN STUDY POPULATION 
Type of 
Cancer 
Control 
(n=60) 
Intervention 
(n=59) 
Breast 19 16 
Cervix 2 2 
Colon 3 3 
Lung 9 8 
Rectal 6 4 
Oesophageal 3 3 
Ovary 1 3 
Prostate 2 2 
Ewing’s 
Sarcoma 
1 4 
Others 14 14 
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Level of 
Education 
No. of 
Population 
Percentage 
(%) 
Illiterate 9 8 
School 63 53 
College 47 39 
         TABLE 4: LEVEL OF EDUCATION IN STUDY POPULATION 
 
FIGURE 4: SHOWS LEVELS OF 
EDUCATION AMONG STUDY 
POPULATION 
29 
TABLE 5. ESTABLISHMENT OF PHARMACEUTICAL CARE  
ELEMENTS OF 
PHARMACEUTICAL CARE 
PERCENTAGE OF 
ESTABLISHMENT (%) 
Patient Counselling 
1.Pre counselling 
2.During the treatment 
3.Discharge medication 
4.Handwritten or printed leaflet 
50 
0 
25 
25 
0 
Patient Information Leaflet 
1.Preparation 
2.Distribution 
50 
50 
0 
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FIGURE 5: SHOWS THE DETAILS OF ESTABLISHMENT OF PHARMACEUTICAL      
CARE 
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Information Sources Control Intervention 
Oncologist 60 59 
Nurse 12 14 
Pharmacist 0 24 
Books 4 3 
Internet 21 18 
Others 14 9 
TABLE 6: INFORMATION SOURCES USED BY THE STUDY POPULATION 
 
FIGURE 6: SHOWS 
INFORMATION SOURCES 
USED BY THE STUDY 
POPULATION IN BOTH 
GROUPS. Control group Intervention group 
Oncologist (100%) 
Internet (35%) 
Others 
(23%) 
Nurse 
(2o%) 
Oncologist 
(100%) 
Pharmacist 
(41%) 
Internet 
(31%) 
Others 
(15%) 
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Adverse Drug Reactions No. of Population 
Diarrhoea 20 
Constipation 18 
Lack of Appetite 13 
Mucositis 20 
PPE 8 
Hyperpigmentation 29 
Extravasation 12 
Onycholysis 10 
Nausea/Vomiting 41 
Neuropathy 13 
Hiccups 11 
Myalgia 22 
Leg Cramps 8 
TABLE 7: ADVERSE DRUG REACTIONS IN STUDY POPULATION 
 
2/28/2014 33 
FIGURE 7: ADVERSE REACTIONS IN STUDY POPULATION 
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TABLE 8: PATIENT SATISFACTION SCORES ON OVERALL AND SUBSET 
EVALUATION 
  
FIGURE 8: SHOWS PATIENT 
SATISFACTION SCORES ON 
OVERALL AND SUBSET 
EVALUATION 
Groups Control 
(n=60) 
Intervention 
(n=59) 
Subset 1 4 4.25 
Subset 2 2.50 4.19 
Subset 3 2.07 3.24 
Subset 4 4.15 4.36 
Overall 3.04 4.12 
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TABLE 9 :  AGE VERSUS SATISFACTION ASSESSMENT   
 Age Variables Control 
(n=60) 
Intervention 
(n=59) 
  
Young adults 
Cancer treatment 4.17 4.43 
Side effects 2.50 4.29 
Complementary treatment 2.17 2.71 
Information presented 4.33 4.29 
Overall 2.67 4.14 
  
Middle-aged 
adults 
Cancer treatment 3.97 4.38 
Side effects 2.30 4.33 
Complementary treatment 1.87 3.13 
Information presented 4.20 4.46 
Overall 2.97 4.29 
          
Older adults 
Cancer treatment 4.00 4.11 
Side effects 2.75 4.04 
Complementary treatment 2.29 3.46 
Information presented 4.04 4.29 
Overall 3.23 3.96 
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FIGURE 9 (a): SHOWS AGE VERSUS SATISFACTION SCORES IN 
CONTROL GROUP 
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FIGURE 9 (b) : SHOWS  AGE VERSUS SATISFACTION SCORES IN 
INTERVENTION GROUP  
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TABLE 10 .EDUCATION VERSUS SATISFACTION ASSESSMENT 
  
Education 
  
Variables 
  
  
Control 
(n=60) 
  
Intervention 
(n=59) 
  
  
Educated 
  
Cancer treatment 3.96 4.24 
Side effects 2.50 4.14 
Complementary 
treatment 
1.88 2.86 
Information 
presented 
4.23 4.43 
Overall 3.08 4.19 
  
  
Not Educated 
Cancer treatment 4.03 4.26 
Side effects 2.50 4.21 
Complementary 
treatment 
2.21 3.45 
Information 
presented 
4.09 4.32 
Overall 3.09 4.08 
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FIGUR 10 (a): EDUCATION VERSUS SATISFACTION SCORE IN CONTROL GROUP 
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FIGURE 10(b): SHOWS THE EDUCATION VERSUS SATISFACTION 
SCORES IN INTERVENTION GROUP 
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One way ANOVA 
   
Sum of 
Squares 
 
df 
 
Mean 
Square 
 
F 
 
Sig. 
Ca treatment Between Groups 1.923 1 1.923 7.214 .008 
Within Groups 31.186 117 .267     
Total 33.109 118       
Side effects Between Groups 84.605 1 84.605 190.549 .000 
Within Groups 51.949 117 .444     
Total 136.555 118       
Complementary  Between Groups 40.765 1 40.765 40.279 .000 
Within Groups 118.411 117 1.012     
Total 159.176 118       
Information source Between Groups 1.262 1 1.262 5.431 .021 
Within Groups 27.175 117 .232     
Total 28.437 118       
Overall Between Groups 34.504 1 34.504 64.783 .000 
Within Groups 62.315 117 .533     
Total 96.819 118       
TABLE 11: SUBSET AND OVERALL ANALYSIS OF SATISFACTION IN CONTROL  
AND INTERVENTION GROUP 
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Value Label 
 
N 
Group 1 Control 60 
2 Intervention 59 
Age 1 young adults 13 
2 middle-aged 
adults 
54 
3 older adults 52 
Education 1 Not educated 72 
2 Educated 47 
 
Source 
 
Dependent  
Variable 
 
Type III 
Sum of 
Squares 
 
df 
 
Mean 
Square 
 
F 
 
Sig. 
 
 
Group * Age 
Ca treatment .932 2 .466 1.813 .168 
Side effects 4.385 2 2.192 5.239 .007 
Complementary  1.651 2 .826 .845 .432 
Information source .027 2 .014 .057 .945 
Overall 4.285 2 2.143 4.088 .019 
 
 
Group * 
Education 
Ca treatment .584 1 .584 2.269 .135 
Side effects 2.307 1 2.307 5.513 .021 
Complementary .486 1 .486 .497 .482 
Information source .078 1 .078 .323 .571 
Overall 1.619 1 1.619 3.089 .082 
TABLE 12: ASSESSMENT OF RELATIONSHIP OF AGE AND EDUCATION ON 
PERCEIVED SATISFACTION  
a) Between Subject  
Factors 
 b)  Multivariate   Analysis 
(MANOVA) 
 6. DISCUSSION 
The prospective interventional study was aimed to assess the 
patient satisfaction on treatment education upon 
establishment of pharmaceutical care in oncology. 
 
• Cancers are mainly occurring in the age group of 40-60 
years, showing 67 patients in this age group followed by 
35 patients in the age group of 60-70 years.  
• These results obtained in our study was similar to the 
results obtained by the study conducted by Ganjewala D 
(2009) in Madhya Pradesh, in which 51% patients fell in 
the age group of 50-75%, followed by 41% in age group of 
25-50 years and 8% in 0-25 years8.  
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• Based on our study, the predominance of patients 
receiving chemotherapy were men (58.82%, N=70) and 
female cancer patients were only 41.17%. These results 
reciprocates the result of study conducted by Zekb A et 
al.,(2008) in Pakistan during  the period of 2000-2004, 
in which out of 1105 cancer patients, 62% were males 
and 38% were females9. 
 
•  In a study conducted by Matsuyama RK, et al., showed, 
out of 138 patients, 36 patients were diagnosed with 
lung cancer, 33 diagnosed as gastro intestinal and the 
follower by 32 patients with breast cancer. Whereas in 
our study out of 119 patients,35 patients were diagnosed 
with breast cancer followed by 22 with gastro intestinal 
and 17 with lung cancer10. 
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•  Level of education plays a role in the understanding of 
information given while counseling. Those with 
comparatively low level of education showed a higher 
demand for information on chemotherapy. 
 
•  Among 119 patients of the study, 53 % had completed a 
school level of education, 39 % completed college level 
education and only 8% were found to be illiterate.   
 
• These results are similar to the study conducted by 
Matsuyama RK et al. Over half the sample had completed 
education above high school while 25% had attained a 
high school diploma or General Education Diploma 
(GED) and 23% had less than high school10. 
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Overall satisfaction measures all the 15 questions in the 
questionnaire. In control group, the average mean score was 3.04 
and in intervention group it improved to 4.12. (p=0.000). The 
significant increase in the intervention group is suggestive to 
highlight the positive influence of pharmaceutical care. The scores 
could be maximized in several areas by considering the 
information needs and demands of the patients. 
The satisfaction scores has sinificanty improved to 4.25, 4.19, 3.24, 
4.36 and 4.12 in the intervention group for the respective subsets 
and overall value .   
• In a study conducted in Germany by Liekwig A et al., (2012), 
the patient received education on cancer treatment as part of 
pharmaceutical care implementation. The study population was 
divided into control group (n= 48) as those receiving 
conventional chemotherapy education and pharmaceutical care 
intervention group (n=50).  
• The global satisfaction score and the subscale analysis showed a 
statistically significant improvement from control group to 
intervention group except for the complementary treatment 
options. Median scores of 4.0,4.0,4.0, 3.9 in control group was 
improved to 4.4,4.3,4.2,4.5,4.4 in intervention group for subscale 
analysis of satisfaction11. 
 
    Age and education wise satisfaction assessment 
• Overall satisfaction among the three age groups in control 
population is 2.67, 2.97 and 3.23 in young adults, middle-aged 
adults and older adults respectively. The satisfaction scores given 
by the intervention population is improved to 4.14, 4.29 and 3.96 
by the respective age groups which shows the improved 
satisfaction level is statistically significant (p=0.019).  
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• This shows that the counselling given was well satisfied by 
the intervention population in all the three age groups. 
Subset 2 also showed significant improvement(p=0.007). 
• As per the study conducted by Walker et.al., patient 
satisfaction was predicted by younger age12. 
 
• Education of patient has also got an impact on satisfactory 
scores. In a study conducted by Rahmqvist et.al., in 
Sweden, patient characteristics and quality dimensions 
related to patient satisfaction was examined and the results 
showed that those with less education are more satisfied 
than the patients with more education whereas is in our 
study educated and not educated groups showed almost 
similar satisfaction and sidnificant satisfaction is observed 
about information given about side effect13.        
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• The information sources used by the patients were examined 
to know the recognition of pharmacist among the population. 
In both the groups, oncologist was the main resource person.  
• Control group patients didn‟t considered pharmacist as their 
information source at all shows that similar pharmaceutical 
services are not provided to patients previously. 41% of 
pharmaceutical care intervention group found pharmacist 
also as their information source in our study. 
• Similar way, Liekweg  et.al, conducted a sequential study in 
Germany to develop a questionnaire measuring patient 
satisfaction with treatment education for cancer patients.. 
Pharmacist seemed to play a minor role as source of 
information (2.2%)in the pre-test and (24%)main test 
groups7. 
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Obstacles 
• Awareness on pharmaceutical services 
among patients and other health care 
professionals is very low. 
• Direct patient-staff relationship 
• Lack of knowledge on psychological 
support 
• Lack of communicating provision with the 
healthcare professionals 
• Lack of professionals 
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CONCLUSION 
• Patients seem to show good response with satisfaction 
towards patient counselling upon pharmaceutical care in 
oncology. 
• Patient satisfaction is a beneficial clinical outcome  to  
improve  patients‟ quality of life. 
• We found significant progress with higher satisfaction 
upon knowledge on side effects and its management by 
the establishment of pharmaceutical care. 
•  This knowledge will improve patient compliance and 
enables then to cope up with further treatment 
modalities.  
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•  Identifying the pharmacist by the patient is the first 
step of progress from which pharmaceutical care 
services can grow further.  
• At present, the profession of pharmacist in a clinical 
set up is at a very low level and scarcely identified by 
patient.  
• Similar studies concentrating on various areas of 
pharmaceutical care can improve the profession as 
well as patients‟ outcome. 
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RECOMMENDATIONS 
2/28/2014 53 
1. Awareness on importance of pharmaceutical services 
among patients and other healthcare providers should 
be created. 
2. Relationship between a pharmacist and a patient 
should develop to assure them that they can also 
contribute to their beneficial health status. 
3.  Practical learning methods for patient counselling 
should include emotional and   psychological aspects 
also. 
4.  Responsibilities of pharmacist are more and currently 
not in an authentic position. This situation must 
change and should start involve in direct plan for 
patient.  
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